Pharm-话题@MedSci

#Pharm#

730篇内容 | 2622人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787758, encodeId=cd561e877582a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Clin Pharmacol Ther：有针对性地利用安慰剂效应可有效减少特应性皮炎患者的瘙痒 , objectType=article, longId=219699, objectId=f15921969996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15921969996, replyNumber=0, likeNumber=76, createdTime=2022-03-30, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15921969996, moduleTitle=Clin Pharmacol Ther：有针对性地利用安慰剂效应可有效减少特应性皮炎患者的瘙痒 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15921969996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787766, encodeId=05791e8776667, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=LEO Pharma宣布FDA核准Adbry™ (tralokinumab)作为特异性靶向作用于中度至重度特应性皮炎成人IL-13的治疗药物, objectType=article, longId=293187, objectId=acae29318e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acae29318e52, replyNumber=0, likeNumber=73, createdTime=2022-03-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acae29318e52, moduleTitle=LEO Pharma宣布FDA核准Adbry™ (tralokinumab)作为特异性靶向作用于中度至重度特应性皮炎成人IL-13的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acae29318e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787747, encodeId=a03e1e8774773, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Pharm Biomed Anal：基于代谢组学研究血府逐瘀胶囊对冠心病大鼠的动态作用, objectType=article, longId=217941, objectId=a3bd21e9413f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3bd21e9413f, replyNumber=0, likeNumber=105, createdTime=2022-01-20, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3bd21e9413f, moduleTitle=J Pharm Biomed Anal：基于代谢组学研究血府逐瘀胶囊对冠心病大鼠的动态作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3bd21e9413f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787744, encodeId=add91e8774416, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药, objectType=article, longId=217612, objectId=ab6b21e61271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6b21e61271, replyNumber=0, likeNumber=51, createdTime=2022-05-01, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6b21e61271, moduleTitle=Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6b21e61271)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787754, encodeId=1ab91e87754b2, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ethnopharmacol：参芪降糖颗粒拮抗胰岛素抵抗的药理机制, objectType=article, longId=219300, objectId=55292193001d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55292193001d, replyNumber=0, likeNumber=86, createdTime=2022-07-08, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55292193001d, moduleTitle=J Ethnopharmacol：参芪降糖颗粒拮抗胰岛素抵抗的药理机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55292193001d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787765, encodeId=11831e8776520, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：血清GDF15可预测丙型肝炎病毒消除后肝癌的发生风险, objectType=article, longId=221186, objectId=d8da22118698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8da22118698, replyNumber=0, likeNumber=92, createdTime=2021-11-30, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8da22118698, moduleTitle=Aliment Pharmacol Ther：血清GDF15可预测丙型肝炎病毒消除后肝癌的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8da22118698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787746, encodeId=d78f1e87746e2, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, objectType=article, longId=217659, objectId=afdf21e659f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afdf21e659f3, replyNumber=0, likeNumber=105, createdTime=2022-04-01, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afdf21e659f3, moduleTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afdf21e659f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787710, encodeId=b3341e8771033, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacology: 脑结构连接有助于预测双相情感障碍药物治疗效果, objectType=article, longId=209821, objectId=20092098211a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20092098211a, replyNumber=0, likeNumber=110, createdTime=2021-10-07, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20092098211a, moduleTitle=Neuropsychopharmacology: 脑结构连接有助于预测双相情感障碍药物治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20092098211a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787763, encodeId=42ca1e877631a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后, objectType=article, longId=220319, objectId=a421220319f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a421220319f1, replyNumber=0, likeNumber=75, createdTime=2022-06-29, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a421220319f1, moduleTitle=Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a421220319f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787711, encodeId=33a11e87711e9, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Heart J Cardiovasc Pharmacother：慢性心力衰竭患者的肾脏保护：关注沙库巴曲/缬沙坦, objectType=article, longId=209879, objectId=1f592098e993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f592098e993, replyNumber=0, likeNumber=74, createdTime=2021-11-29, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f592098e993, moduleTitle=Eur Heart J Cardiovasc Pharmacother：慢性心力衰竭患者的肾脏保护：关注沙库巴曲/缬沙坦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f592098e993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787715, encodeId=d8241e877152a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：elobixibat通过影响分泌性胆汁酸来改善慢性便秘, objectType=article, longId=211217, objectId=e10121121e32, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e10121121e32, replyNumber=0, likeNumber=83, createdTime=2021-09-15, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e10121121e32, moduleTitle=Aliment Pharmacol Ther：elobixibat通过影响分泌性胆汁酸来改善慢性便秘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e10121121e32)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787719, encodeId=86871e8771961, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=因首席执行官被指控篡改数据等学术不端，Athira Pharma 市值1天直接蒸发了17亿人民币, objectType=article, longId=213006, objectId=36f12130064c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36f12130064c, replyNumber=0, likeNumber=57, createdTime=2022-04-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36f12130064c, moduleTitle=因首席执行官被指控篡改数据等学术不端，Athira Pharma 市值1天直接蒸发了17亿人民币, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36f12130064c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787705, encodeId=861a1e87705a6, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据, objectType=article, longId=207251, objectId=158620e25189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=158620e25189, replyNumber=0, likeNumber=90, createdTime=2022-01-28, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=158620e25189, moduleTitle=Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=158620e25189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787732, encodeId=bec51e87732e6, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Aliment Pharmacol Ther：泰戈拉赞vs.兰索拉唑治疗胃溃疡的效果, objectType=article, longId=214846, objectId=a4bf2148463c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4bf2148463c, replyNumber=0, likeNumber=88, createdTime=2022-04-18, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4bf2148463c, moduleTitle=Aliment Pharmacol Ther：泰戈拉赞vs.兰索拉唑治疗胃溃疡的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4bf2148463c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787716, encodeId=2f891e87716bb, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacology：神经黑色素敏感磁共振成像有助于监测多巴胺相关的精神运动减缓疾病, objectType=article, longId=212040, objectId=546a212040c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546a212040c0, replyNumber=0, likeNumber=85, createdTime=2021-09-20, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546a212040c0, moduleTitle=Neuropsychopharmacology：神经黑色素敏感磁共振成像有助于监测多巴胺相关的精神运动减缓疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=546a212040c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787725, encodeId=cb5f1e8772509, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int Immunopharmacol：肠道微生物群通过调节TLR4/NF-kB信号通路对抗LPS引起的急性肺损伤, objectType=article, longId=214156, objectId=f054214156bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f054214156bc, replyNumber=0, likeNumber=94, createdTime=2021-08-14, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f054214156bc, moduleTitle=Int Immunopharmacol：肠道微生物群通过调节TLR4/NF-kB信号通路对抗LPS引起的急性肺损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f054214156bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787727, encodeId=93861e877275c, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacol:双侧丘脑前辐射FA值高是BD的保护因素, objectType=article, longId=214534, objectId=73c921453450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73c921453450, replyNumber=0, likeNumber=72, createdTime=2022-06-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73c921453450, moduleTitle=Neuropsychopharmacol:双侧丘脑前辐射FA值高是BD的保护因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73c921453450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787729, encodeId=5b591e8772939, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur J Clin Pharmacol：不同CYP2C19等位基因的患者，每天两次的雷贝拉唑半剂量对酸抑制的影响, objectType=article, longId=214795, objectId=32f8214e959f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f8214e959f, replyNumber=0, likeNumber=72, createdTime=2022-01-14, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f8214e959f, moduleTitle=Eur J Clin Pharmacol：不同CYP2C19等位基因的患者，每天两次的雷贝拉唑半剂量对酸抑制的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f8214e959f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787728, encodeId=c8541e87728b4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropsychopharmacol：母亲产前压力影响孩子大脑, objectType=article, longId=214535, objectId=217f2145357e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=217f2145357e, replyNumber=0, likeNumber=77, createdTime=2021-08-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=217f2145357e, moduleTitle=Neuropsychopharmacol：母亲产前压力影响孩子大脑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=217f2145357e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787735, encodeId=fffe1e8773529, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=万春医药CEO黄岚博士荣膺“PharmaVOICE生物科学100人”, objectType=article, longId=215697, objectId=ab2221569e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab2221569e71, replyNumber=0, likeNumber=74, createdTime=2022-06-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab2221569e71, moduleTitle=万春医药CEO黄岚博士荣膺“PharmaVOICE生物科学100人”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab2221569e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Clin Pharmacol Ther：有针对性地利用安慰剂效应可有效减少特应性皮炎患者的瘙痒

2022-03-30

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

LEO Pharma宣布FDA核准Adbry™ (tralokinumab)作为特异性靶向作用于中度至重度特应性皮炎成人IL-13的治疗药物

2022-03-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

J Pharm Biomed Anal：基于代谢组学研究血府逐瘀胶囊对冠心病大鼠的动态作用

2022-01-20

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药

2022-05-01

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

J Ethnopharmacol：参芪降糖颗粒拮抗胰岛素抵抗的药理机制

2022-07-08

柳叶一刀 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：血清GDF15可预测丙型肝炎病毒消除后肝癌的发生风险

2021-11-30

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效

2022-04-01

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacology: 脑结构连接有助于预测双相情感障碍药物治疗效果

2021-10-07

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后

2022-06-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur Heart J Cardiovasc Pharmacother：慢性心力衰竭患者的肾脏保护：关注沙库巴曲/缬沙坦

2021-11-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：elobixibat通过影响分泌性胆汁酸来改善慢性便秘

2021-09-15

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

因首席执行官被指控篡改数据等学术不端，Athira Pharma 市值1天直接蒸发了17亿人民币

2022-04-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据

2022-01-28

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Aliment Pharmacol Ther：泰戈拉赞vs.兰索拉唑治疗胃溃疡的效果

2022-04-18

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacology：神经黑色素敏感磁共振成像有助于监测多巴胺相关的精神运动减缓疾病

2021-09-20

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Int Immunopharmacol：肠道微生物群通过调节TLR4/NF-kB信号通路对抗LPS引起的急性肺损伤

2021-08-14

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacol:双侧丘脑前辐射FA值高是BD的保护因素

2022-06-19

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur J Clin Pharmacol：不同CYP2C19等位基因的患者，每天两次的雷贝拉唑半剂量对酸抑制的影响

2022-01-14

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Neuropsychopharmacol：母亲产前压力影响孩子大脑

2021-08-27

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

万春医药CEO黄岚博士荣膺“PharmaVOICE生物科学100人”

2022-06-23

科室
- - 订阅+
  - 更多科室
工具
服务